Related Experiment Video

Updated: Jun 26, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

[Reverse cholesterol transport processes and their role in artherosclerosis regression]

Angelika Chachaj1, Katarzyna Drozdz, Andrzej Szuba

  • 1Department of Internal Medicine, Wroclaw Medical University, 4 Pasteur St., 50-367 Wroclaw, Poland. angelika_chachaj@wp.pl

Postepy Biochemii
|December 31, 2008
PubMed

Insights

Atherosclerosis can reverse, but the process is not fully understood. This review focuses on reverse cholesterol transport as a key mechanism in plaque regression.

Area of Science:

  • Cardiovascular Science
  • Pathology
  • Biochemistry

Context:

  • Atherosclerosis is a chronic inflammatory disease characterized by plaque buildup in arteries.
  • Evidence suggests atherosclerosis can undergo regression, but mechanisms are incompletely understood.
  • Reverse cholesterol transport (RCT) is implicated in the removal of excess cholesterol from plaques.

Purpose:

  • To review current data on atherosclerosis regression.
  • To highlight the role of reverse cholesterol transport in plaque regression.
  • To synthesize knowledge on mechanisms driving atherosclerosis reversal.

Summary:

  • Atherosclerosis regression involves cholesterol removal from plaques, potentially via RCT.
  • Other contributing factors include macrophage migration, inflammation inhibition, and endothelial repair.
  • This review consolidates evidence on regression, emphasizing RCT pathways.

Impact:

  • Enhances understanding of atherosclerosis reversibility.
  • Identifies key pathways for therapeutic intervention.
  • Provides a foundation for future research into plaque regression treatments.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...